PERIMAG
Live / Registered — Registered — partial invalidation of extension of protection (as of 17 Apr 2024)
What this means for you
Registered since 08 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79192642
- Registration number
- 5258234
- Mark type
- Stylized text
- Filed
- 02 Jun 2016
- Published for opposition
- 23 May 2017
- Registered
- 08 Aug 2017
- Attorney of record
- Martin R. Geissler
Goods and services
- Class 001 — Chemicals: Chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed primarily of magnetizable material for use as contrast agents in Magnetic Resonance Imaging and Magnetic Particle Imaging for use in commercial and scientific applications; nanoparticles and microparticles composed primarily of magnetizable material for use in homing and tracking of stem cells in regenerative medicine and for hyperthermia applications for use in commercial and scientific applications; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed of both magnetizable material and organic polymers for use in biomedical research; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles that are equipped on their surface with functional properties, namely, antibody-coated, radionuclide doped, and fluorescently labeled for pharmaceutical research, cancer diagnostics and treatment research or stem cell treatment research
- Class 005 — Pharmaceuticals: [Diagnostic preparations for medical purposes, namely, magnetizeable nano and micro particles for use in carrier-supported immunologice medical test analysis, in biochemistry or clinical chemistry, in transport- and separation-methods for medical testing for the presence of nucleic acids, tumor markers or other disease-relevant biomolecules, and in imaging tests; therapeutic pharmaceuticals, namely, magnetizeable nano and micro particles for the treatment of cancer, auto-immune diseases, or cardiovascular diseases; pharmaceutical and veterinary products, namely, magnetizeable nano and micro particles for use in targeted drug delivery and physical therapy methods, such as magnetic field-induced hyperthermia]
Owner
Prosecution history
- 02 Apr 2026 — INTERNATIONAL REGISTRATION RENEWED
- 12 Apr 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 18 Feb 2025 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 13 Feb 2025 — GENERIC MADRID TRANSACTION SENT TO IB
- 13 Feb 2025 — GENERIC MADRID TRANSACTION CREATED
- 18 Dec 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 17 Dec 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 18 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 17 Apr 2024 — REGISTERED - PARTIAL SEC 71 ACCEPTED
- 09 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Dec 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 08 Aug 2023 — TEAS SECTION 71 RECEIVED
- 08 Aug 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 Dec 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 Nov 2017 — FINAL DISPOSITION NOTICE SENT TO IB